22.02
-0.67(-2.95%)
Currency In USD
| Previous Close | 22.69 |
| Open | 22.54 |
| Day High | 22.75 |
| Day Low | 21.54 |
| 52-Week High | 28.42 |
| 52-Week Low | 10.14 |
| Volume | 111,390 |
| Average Volume | 156,680 |
| Market Cap | 285.59M |
| PE | -0.83 |
| EPS | -26.68 |
| Moving Average 50 Days | 21.03 |
| Moving Average 200 Days | 18.15 |
| Change | -0.67 |
If you invested $1000 in Cidara Therapeutics, Inc. (CDTX) 10 years ago, it would be worth $70.17 as of May 29, 2025 at a share price of $22.02. Whereas If you bought $1000 worth of Cidara Therapeutics, Inc. (CDTX) shares 5 years ago, it would be worth $304.14 as of May 29, 2025 at a share price of $22.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025
GlobeNewswire Inc.
May 15, 2025 12:00 PM GMT
SAN DIEGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that it will hos
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
GlobeNewswire Inc.
May 13, 2025 12:00 PM GMT
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will p
Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development
GlobeNewswire Inc.
May 01, 2025 12:00 PM GMT
SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that Nicole Davarpanah, M.D.,